Posted in Web Why Novavax Could Become a Latecomer Leader in the COVID … January 29, 2021 Novavax (NASDAQ: NVAX) doesn’t rank among the top three leaders in the coronavirus vaccine race. However, don’t count the small biotech out. In this Motley Fool Live video recorded on Jan. 6, 2021 … https://www.nasdaq.com/articles/why-novavax-could-become-a-latecomer-leader-in-the-covid-vaccine-race-2021-01-16